Get the Stockscreener App
13.78
0.58%
-0.08
Avantor Inc stock is traded at $13.78, with a volume of 10.85M.
It is down -0.58% in the last 24 hours and up +39.19% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$13.86
Open:
$13.42
24h Volume:
10.85M
Relative Volume:
1.10
Market Cap:
$9.41B
Revenue:
$6.55B
Net Income/Loss:
$-551.40M
P/E Ratio:
-17.05
EPS:
-0.8082
Net Cash Flow:
$438.90M
1W Performance:
+20.45%
1M Performance:
+39.19%
6M Performance:
+26.19%
1Y Performance:
+2.53%
1-Day Range:
$13.42
$13.93
1-Week Range:
$11.36
$14.92
52-Week Range:
$7.265
$15.93
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
13.78 | 8.03B | 6.55B | -551.40M | 438.90M | -0.8082 |
ISRG
Intuitive Surgical Inc
|
353.33 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
165.70 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
68.94 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
39.28 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
211.00 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Avantor earnings up next: Can turnaround stem market share losses? By Investing.com - Investing.com South Africa
Earnings To Watch: Avantor (AVTR) Reports Q2 Results Tomorrow - Yahoo Finance
Avantor Inc (AVTR) Cash Flow - TradingKey
Form 4 Avantor Inc For: 27 July By Investing.com - Investing.com Canada
Avantor Inc (AVTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Avantor Inc (AVTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVTR|Avantor Inc|Price:11.765|Chg%:+0.325 - TradingKey
AVTR|Avantor Inc|Price:11.440|Chg%:+0.095 - TradingKey
Avantor Inc (AVTR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Avantor, Inc. (AVTR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Avantor Inc (AVTR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Avantor Inc (AVTR) Institutional Confidence - TradingKey
Avantor, Inc. Revenue Breakdown – SWB:AVG - TradingView
Avantor (AVTR) Expands NuSil HIV Prevention Partnership With The Population Council - Yahoo Finance
Avantor Inc (AVTR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ETFs Investing in Avantor, Inc. Stocks - TradingView
Avantor, Inc. Revenue Breakdown – BMV:AVTR - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Avantor Inc (AVTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance Singapore
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor Inc (AVTR) Stock Up 3.6% and Still Undervalued -- GF Sco - GuruFocus
Avantor stock holds steady as investors weigh recent earnings and life sciences demand - Ad-hoc-news.de
AVTR: Avantor Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Avantor stock trades steady as investors weigh recent earnings and life sciences demand - AD HOC NEWS
Avantor Inc (AVTR) Shares Fall 3.7% -- What GF Score of 61 Tells Investors - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation | NYSE:AVTR | Press Release - Stockhouse
Avantor Inc. (AVTR) Q1 2026 Earnings: EPS Surprise Lifts Results Despite Revenue Not Disclosed and Slight Share DeclineCEO Earnings Statement - po-news-eg.net
Avantor, Inc. Announces Amendment No. 15 to Credit Agreement, Extending Euro Term Loan Maturity to 2032 - Minichart
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor Lowers Borrowing Costs by Refinancing €374.2 Million Euro-Denominated Term Loans with Credit Agreement Amendment - Kalkine Media
Avantor Unit Enters Amendment No. 15 To Credit Agreement On July 14, 2026SEC Filing - TradingView
Avantor Refinances €374.2 Million Euro Term Loans at EURIBO + 2.00% Under Credit Amendment - TradingView
Avantor (NYSE: AVTR) refinances €374,208,296.62 in Euro term loans - Stock Titan
Trading Systems Reacting to (AVTR) Volatility - Stock Traders Daily
Will Avantor (AVTR) beat estimates again in its next earnings report? - MSN
Is Avantor (AVTR) Quietly Redefining Its Healthcare Role With NuSil’s HIV-Prevention Partnership? - simplywall.st
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor Jumps 6.2% Amid Sector-Wide Rally - AlphaStreet
Avantor Inc (AVTR) Stock Up 6.9% and Still Undervalued -- GF Sco - GuruFocus
Avantor expands partnership for HIV prevention ring development By Investing.com - Investing.com Nigeria
Avantor expands partnership for HIV prevention ring development - Investing.com
Avantor expands collaboration to develop a thre... - Pluang
New HIV prevention ring could cut use from 12 rings to four - Stock Titan
Price to earnings forward of Avantor, Inc. – LSX:A2PJN6 - TradingView
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.31, Implies 1% Downside - TradingView
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avantor Inc Stock (AVTR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dingemans Simon | Director |
May 01 '26 |
Buy |
8.14 |
25,000 |
203,500 |
25,000 |
| MEHRA SANJEEV K | Director |
Mar 10 '26 |
Buy |
8.01 |
125,000 |
1,001,250 |
475,000 |
| LUCIER GREGORY T | Director |
Feb 19 '26 |
Buy |
9.16 |
50,000 |
458,000 |
50,000 |
| SUMME GREGORY L | Director |
Feb 12 '26 |
Buy |
9.40 |
100,000 |
940,000 |
400,000 |
| MEHRA SANJEEV K | Director |
Dec 05 '25 |
Buy |
11.09 |
350,000 |
3,881,500 |
350,000 |
| Ligner Emmanuel | President and CEO |
Nov 17 '25 |
Buy |
11.35 |
87,500 |
993,125 |
283,424 |
2.49%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):